Recent research have converged on the overlap of GLP|GIP|GCGR stimulant therapies and dopamine signaling. While GCGR stimulators are commonly employed for managing type 2 T2DM, their potential impacts on reward circuits, specifically governed by dopamine networks, are receiving significant interest. This paper details a summary overview of curre… Read More